Prime editing is an advanced gene editing technology that enables precise DNA corrections without introducing double-stranded ...

A new milestone for CRISPR: prime editing enters clinical trials, enabling precise, programmable DNA changes for treating ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

Prime Medicine’s proprietary Prime Editing technology allows for precise editing, correction, insertion, and deletion of DNA sequences. This approach extends the reach of gene editing beyond current ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Genome editing technologies such as CRISPR/Cas9, base editing, and prime editing are rapidly transforming our ability to ...

On Tuesday, Citi analysts downgraded Prime Medicine (NASDAQ: PRME) stock from Buy to Neutral and significantly reduced the price target to $1.50 from the previous $10.00.Currently trading at $1.29 ...